pET302-6His-dCas9-Halo Citations (4)

Originally described in: CASFISH: CRISPR/Cas9-mediated in situ labeling of genomic loci in fixed cells.
Deng W, Shi X, Tjian R, Lionnet T, Singer RH Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11870-5. doi: 10.1073/pnas.1515692112. Epub 2015 Aug 31. PubMed Journal

---

Articles Citing pET302-6His-dCas9-Halo

Articles
Nuclease dead Cas9 is a programmable roadblock for DNA replication. Whinn KS, Kaur G, Lewis JS, Schauer GD, Mueller SH, Jergic S, Maynard H, Gan ZY, Naganbabu M, Bruchez MP, O'Donnell ME, Dixon NE, van Oijen AM, Ghodke H. Sci Rep. 2019 Sep 16;9(1):13292. doi: 10.1038/s41598-019-49837-z. PubMed
A Targeted and Tuneable DNA Damage Tool Using CRISPR/Cas9. Emmanouilidis I, Fili N, Cook AW, Hari-Gupta Y, Dos Santos A, Wang L, Martin-Fernandez ML, Ellis PJI, Toseland CP. Biomolecules. 2021 Feb 15;11(2):288. doi: 10.3390/biom11020288. PubMed
Targeted degradation of transcription factors by TRAFTACs: TRAnscription Factor TArgeting Chimeras. Samarasinghe KTG, Jaime-Figueroa S, Burgess M, Nalawansha DA, Dai K, Hu Z, Bebenek A, Holley SA, Crews CM. Cell Chem Biol. 2021 May 20;28(5):648-661.e5. doi: 10.1016/j.chembiol.2021.03.011. Epub 2021 Apr 8. PubMed
A chromatinized origin reduces the mobility of ORC and MCM through interactions and spatial constraint. Sanchez H, Liu Z, van Veen E, van Laar T, Diffley JFX, Dekker NH. Nat Commun. 2023 Oct 23;14(1):6735. doi: 10.1038/s41467-023-42524-8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.